RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.63) per share. This is unchanged from the same period last year.
CLSA Downgrades Waterdrop to Outperform
CLSA downgrades Waterdrop (NYSE:WDH) from Buy to Outperform.
Related Posts
Heartland Express Acquires Pennsylvania-Based Smith Transport For $170M
Heartland Express, Inc. (NASDAQ:HTLD) has acquired 100% of the equity of dry van truckload carrier Smith Transport, Inc. and related entities…
Greif Boosts Price For URB, Tube And Core Packaging Products
Industrial packaging products provider Greif Inc (NYSE:GEF) has increased the price for all grades of uncoated recycled paperboard (URB) by $70 per…